SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-146844
Filing Date
2016-09-27
Accepted
2016-09-27 16:53:53
Documents
9
Period of Report
2016-09-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-19111_38k.htm 8-K 39209
2 EX-4.1 a16-19111_3ex4d1.htm EX-4.1 111867
3 EX-5.1 a16-19111_3ex5d1.htm EX-5.1 13242
4 EX-10.1 a16-19111_3ex10d1.htm EX-10.1 240955
5 EX-10.2 a16-19111_3ex10d2.htm EX-10.2 59572
6 EX-99.1 a16-19111_3ex99d1.htm EX-99.1 7410
7 GRAPHIC g191113ksi001.jpg GRAPHIC 5393
8 GRAPHIC g191113ksi002.jpg GRAPHIC 3551
9 GRAPHIC g191113lgi001.jpg GRAPHIC 6066
  Complete submission text file 0001104659-16-146844.txt   494648
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 161904985
SIC: 2834 Pharmaceutical Preparations